Genmab A/S (GMAB) PT Raised to $34 at Leerink Partners
Tweet Send to a Friend
(Updated - September 29, 2025 1:09 PM EDT)
Leerink Partners analyst Jonathan Chang raised the price target on Genmab ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink Partners analyst Jonathan Chang raised the price target on Genmab ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
